Short Patient Survey for REMAP-ILD: Have your voice heard

November 2023

Do you have a diagnosis of pulmonary fibrosis? We would like to know what you think about taking part in clinical trials to find new treatments.

Take part in the online survey.

Designed by patients, for patients.

You can help make a difference to pulmonary fibrosis research by having your voice heard.

We want more patients to be able to take part in clinical trials and help to find treatments faster for everyone affected by the disease.  By completing this short survey, you will be improving our understanding of what patients want and need from a clinical trial.  

Taking part in this online survey takes about 10 minutes.  

What is REMAP-ILD?

REMAP-ILD  is a bold and ambitious project that aims to find treatments faster for patients affected by pulmonary fibrosis. The project is currently at the funding application stage.  Scientists in different countries around the world are applying for regional funding to start the trial. We plan to provide an update about the project’s progress  in Spring 2024.

If you would like to be kept up to date with the REMAP-ILD activities, please email to express your interest.